Last Price
83.88
Today's Change
+44.12 (110.96%)
Day's Change
47.67 - 98.00
Trading Volume
954,388
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Ram Aiyar MBA, Ph.D. Mr. Ram Aiyar MBA, Ph.D.
Full Time Employees: 92 92
IPO Date: 2019-10-03 2019-10-03
CIK: 0001703647 0001703647
ISIN: US5009461089 US5009461089
CUSIP: 500946108 500946108
Beta: 0.00 0.00
Last Dividend: 0.00 0.00
Dcf Diff: -3.73 -3.73
Dcf: 86.93 86.93
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.